Dr. Ober is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
29201 Telegraph Rd
Suite #606
Southfield, MI 48034Phone+1 248-356-8610Fax+1 248-356-6473
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Surgical Retina and Vitreous, 2003 - 2005
- New York Presbyterian Hospital (Cornell Campus)Residency, Ophthalmology, 1999 - 2003
- Corewell Health East Beaumont (Royal Oak)Internship, Transitional Year, 1999 - 2000
- Wayne State University School of MedicineClass of 1999, MD
- Cornell UniversityBA, Chemistry, 1991 - 1995
Certifications & Licensure
- NY State Medical License 2000 - Present
- MI State Medical License 1999 - 2027
- CA State Medical License 2003 - 2025
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FAAO) American Academy of Ophthalmology
Publications & Presentations
PubMed
- 12 citationsConfirmation of Luteinizing Hormone (LH) in Living Human Vitreous and the Effect of LH Receptor Reduction on Murine ElectroretinogramTammy Z. Movsas, Kwoon Y. Wong, Michael D. Ober, Robert E. Sigler, Zhenmin Lei
Neuroscience. 2018-08-10 - 35 citationsStellate Nonhereditary Idiopathic Foveomacular RetinoschisisMichael D. Ober, K. Bailey Freund, Manthan Shah, Shareef Ahmed, Tamer H. Mahmoud
Ophthalmology. 2014-07-01 - 68 citationsA pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy (case reports)M. Torres-Soriano, Gerardo Garcia-Aguirre, Veronica Kon-Jara, Orlando Ustariz-Gonzáles, Maura Lucy Abrahám-Marin
Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2008-06-04
Press Mentions
- Diagnosis and Management of Pathologic MyopiaNovember 1st, 2019
- SUBSPECIALTY NEWS: Results for Combination Therapy for DME, FDA Asks for Information on Xipere, Depo-Medrol Retinal Toxicity, and MoreOctober 1st, 2019
Professional Memberships
- Fellow
- The Retina SocietyMember
- Association for Research in Vision and Ophthalmology (ARVO)Member
- Member
- Fellow
- The Macula SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: